MMMateo S. Andrade Mier

Mateo S. Andrade Mier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mateo S. Andrade Mier has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Purpose‐Adaptable Reinforced 3D Hyaluronic‐Acid Based Platform to Study Pathomechanisms of the Central Nervous System

    by Nicoletta Murenu, Esra Tuerker, Anna‐Lena Wiessler, Jessica Faber, Ievgenii Liashenko, Jeanette Weigelt, Jörg Tessmar, Paul D. Dalton, Sibylle Jablonka, Mateo S. Andrade Mier, et al.

    Three‐dimensional (3D) models to study human disease mechanisms have demonstrated that the third dimension is an essential component for neuronal maturation and function. However, 3D neuronal cell culture is challenging due to their ultra‐soft nature and specific extracellular matrix (ECM) organization. This study presents a microfiber reinforcement approach, combining primary mouse spinal cord neurons (SCNs) in a purpose‐adaptable hyaluronic‐acid‐based matrix with melt electrowritten (MEW) frames to study disease mechanisms. The importance of laminins (LNs) is evaluated, which are vital for neuronal adhesion and maturation. Astrocytes (ACs) are mandatory in brain development and function by secretion of signal molecules, maintaining ion homeostasis, clearing of neurotransmitters, and by actively modulating neuronal activity. Three combinations are compared (i) isolated primary SCN, (ii) SCN with ACs (SCN‐AC) and (iii) SCN‐AC and LNs (SCN‐AC‐LN). Multimodal analysis by comparing protein expression, dendrite length, complex mechanical properties, and network functionality via Ca 2+ ‐imaging allows validation of structural and functional neuronal network development. The suitability of the 3D model to study pathomechanisms is demonstrated for Stiff Person Syndrome (SPS). For the first time, functional impairment of spinal cord neurons by patient‐derived autoantibodies characteristic for SPS is recapitulated in a 3D spinal cord model platform adaptable to other disease types.


  • Open Access

    Bioprinting Organs—Science or Fiction?—A Review From Students to Students

    by Nicoletta Murenu, Camilla Mussoni, Mateo S. Andrade Mier, Paula Buettner, Nathaly Chicaiza‐Cabezas, Yi‐Yu Robin Dai, Jessica Faber, Maren Fiedler, Zan Lamberger, Xuen Jen Ng, et al.

    Bioprinting technology has attracted significant attention in the field of tissue engineering, enabling the precise placement of cells, biomaterials, and biomolecules to construct 3D tissue and organ structures. This review explores the feasibility of bioprinting functional organs by assessing current advancements in the field. A poll conducted among people from diverse backgrounds reveals common optimism regarding the future of organ bioprinting and its role in medicine and other fields. The article is conceptualized from a student‐to‐student perspective to provide a brief overview of key aspects of bioprinting, including bioinks, crosslinking techniques, bioprinting methods, and the maturation process required to develop functional tissues. Furthermore, it highlights recent progress in printing specific tissues as models for studying healthy and diseased tissues as well as implantable grafts. While there are still significant challenges that require the integration of technologies from engineering, biomaterials science, cell biology, physics, and medicine, ongoing research continues to address these complexities. The possibilities of bioprinting tissues and organs go beyond minimizing dependence on animal testing and advancing drug discovery; indeed, this approach also opens the door to accessible personalized medicine and presents a viable solution to the worldwide organ donor shortage.